Abstract:Background: Based on an automatic integrated gene detection system (AIGS) for rapid detecting TERTp mutations, it further enables accurate intraoperative subtype diagnosis of gliomas and provides a tumor molecular margin determination scheme for TERTp-mutated GBM.Methods: AIGS was used to detect the mutations of the IDH and TERTp genes that occurred in 34 glioma patients intraoperatively, with timely feedback to neurosurgeons and pathologists. The technique's accuracy was evaluated by comparing it to next-generation sequencing (NGS) or Sanger sequencing. The practical value of this technique in clinical practice was assessed by comparing the accuracy of glioma subtype diagnoses made by pathologists before and after obtaining TERTp mutation results. The clinical viability of this technique for assisting intraoperative precision excision of TERTp-mutated GBM was evaluated by detecting tumor cavity TERTp mutations to rapidly define tumor molecular margins in IDH-wild and TERTp-mutated GBM patients. The study has been registered at http://www.chictr.org.cn with the unique identifier ChiCTR2100048172.Findings: The AIGS results showed that IDH mutations were detected in 44.1% of patients, all with IDH1 R132H mutations; TERTp mutations were detected in 50% of patients, including 12 (35.3%) with C228T mutations and 5 (14.7%) with C250T mutations. TERTp mutations were detected in 8 patients with IDH mutations and 1p/19q co-deletions, including 6 (75%) with C228T mutations and 2 (25%) with C250T mutations. With NGS/Sanger sequencing and chromosome detection as the gold standard, the accuracy of AIGS results was 100%. After obtaining the TERTp mutation detection results, the percentage of oligodendroglia in the intraoperative integrated diagnosis made by the pathologists increased from 0% to 23.5%, while the accuracy of the glioma subtype diagnosis increased by 23.5%. Using AIGS to detect TERTp mutations, we defined the tumor molecular margins in 2 GBM patients and achieved complete resection of GBM at the molecular level. In the present study, overall survival and progression-free survival after surgery in TERTp-mutated GBM patients were not statistically significantly different from TERTp-wild GBM patients (p = 0.13 for overall survival and p = 0.77 for progression-free survival).Interpretation: Using AIGS for rapid detection of TERTp mutations enables accurate diagnosis of glioma subtypes intraoperatively and clarifies the tumor molecular margins of TERTp-mutated GBM, which allows complete resection of GBM at the molecular level and improves the survival prognosis of patients.Funding Research on the future application prospect of classical gene marker Kit (Contract No. 6010122006), Key Clinical Research Project of Clinical Research Center of Shandong University (2020SDUCRCA011), Taishan Pandeng Scholar Program of Shandong Province (No. tspd20210322) and Taishan Scholar Program of Shandong Province (No. tsqn202211316).Trial Registration: The study has been registered at http://www.chictr.org.cn with the unique identifier ChiCTR2100048172.Funding: Research on the future application prospect of classical gene marker Kit (Contract No. 6010122006), Key Clinical Research Project of Clinical Research Center of Shandong University (2020SDUCRCA011), Taishan Pandeng Scholar Program of Shandong Province (No. tspd20210322) and Taishan Scholar Program of Shandong Province (No. tsqn202211316).Declaration of Interest: The authors have declared that no conflict of interest exists.Ethical Approval: The study was approved by the ethics committee of Qilu Hospital of Shandong University and registered with the National Clinical Research Centre, and all patients signed a written informed consent form.

Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma

291 Supra-maximal Extent of Resection is Associated With Improved Progression-Free Survival in Patients With IDH Wild-Type Glioblastoma Once Negative TERT Promoter Molecular Margins are Achieved

Extent of Resection Thresholds in Molecular Subgroups of IDH-Wildtype Glioblastoma

Extent of Resection Thresholds in Molecular Subgroups of Newly Diagnosed Isocitrate Dehydrogenase–Wildtype Glioblastoma

Influence of Surgical Resection on Survival in Glioblastoma with Multiple Localizations—a Multi-Center Retrospective Analysis

Radt-38. Clinical, Molecular And Imaging Features Associated With Long Term Survival In Glioblastoma Patients

Incorporating Supramaximal Resection into Survival Stratification of IDH -Wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning Analysis

Glioblastoma: A Retrospective Analysis of the Role of the Maximal Surgical Resection on Overall Survival and Progression Free Survival

Nimg-15. Rapid Early Progression After Surgery On Pre-Radiation Planning Mri For Idh-Wildtype Glioblastoma

Surg-47. Supramaximal Resection Improves Overall Survival In Patients With Mgmt-Unmethylated Glioblastoma

Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma

205 Microglia-Mediated Survival Outcomes in Preoperative Radiation for Glioblastoma: Insights From a Preclinical Model

Optimizing Recurrent Glioblastoma Salvage Treatment: A Multicenter Study Integrating Genetic Biomarkers From the Korean Radiation Oncology Group (21-02)

Intraoperative Rapid Molecular Diagnosis for Glioma Subtyping and Precise Resection of TERTp-Mutated Glioblastoma：A Prospective Cohort Study

Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study

Nimg-58. Machine Learning-Generated Whole-Brain Radio-Pathomic Tumor Probability Maps Within Contrast-Enhancement Stratify Survival In Glioblastoma Patients Undergoing Gross-Total Resection

Radt-40. Evaluation Of Smaller Clinical Target Volumes And Patterns Of Progression In Patients With Newly Diagnosed Glioblastoma To Inform Future Directions In Radiation Treatment Planning

Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection

The Impact of Extensive Surgical Resection of Butterfly Glioblastomas on Outcomes in the Presence of TERT Mutation and EGFR Amplification: A Retrospective Cohort Study

Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group

Radt-17. Fractionated Reirradiation Of Recurrent Idh Wildtype Glioblastoma: Higher Reirradiaiton Dose And Safety